Lawson Health Research Institute
London, Ontario, N6C2R5, Canada
NCT Number: NCT04426071
Document and evaluate the impact of societal restrictions due to the pandemic on SCI- and ABI-related disability and functional impairments, and the resultant effects on psychological wellbeing, physical wellbeing and quality of life for those with SCI/ABI.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
London, Ontario, N6C2R5, Canada
The investigators will conduct a longitudinal survey to examine the impact of COVID19 on those with SCI and ABI. An a priori sample size of 117 individuals based on an alpha level of .05 and level of acceptable error at 3% was calculated. Anticipating for loss to follow up rate of up to 20%, a total of 142 participants will be recruited. Patients will be recruited among those who attend virtual medical appointments at Parkwood Institute for ABI and SCI. We will also liaise with SCI-Ontario and the Ontario Brain Injury Association to assist in the recruitment of additional participants. Those who consent will complete an online survey on enrollment into the study, and subsequently at 3 and 6 months. Demographic data of the individuals participating in the study will be recorded. Participants' access to health care services will be evaluated using the following subdomains: medical care, complementary care, medications/equipment, satisfaction/acceptability, affordability, ability to engage, and indirect support.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: baseline, 3 months, 6 months
Fear of COVID-19 Questionnaire
Time frame: baseline, 3 months, 6 months
NeuroQol SF v1.0 - Ability to Part. in SRA
Time frame: baseline, 3 months, 6 months
NeuroQol SF v1.0 - Depression
Time frame: baseline, 3 months, 6 months
NeuroQol SF v1.0 - Pos. Affect & Well-Being
Time frame: baseline, 3 months, 6 months
NeuroQol SF v1.0 - Anxiety
Time frame: baseline, 3 months, 6 months
NeuroQol SF v1.0 - Fatigue
Time frame: baseline, 3 months, 6 months
NeuroQol SF v1.0 - Emotional & Beh. Dyscontrol
Time frame: baseline, 3 months, 6 months
NeuroQol SF v1.0 - Satisfaction w SRA
Time frame: baseline, 3 months, 6 months
NeuroQol SF v1.0 - Sleep Disturbance
Time frame: baseline, 3 months, 6 months
NeuroQol SF v1.0 - Stigma
Time frame: baseline, 3 months, 6 months
NeuroQol SF v1.0 - Cognitive Function
Time frame: baseline, 3 months, 6 months
23 questions about strategies to social distance
Time frame: baseline, 3 months, 6 months
22 questions about social distancing
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Other
COVID-19 and Disability: The Impact of a Societal Lockdown on Those With Spinal Cord and Brain Injuries
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05951985
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Fort Smith, Arkansas, United States
View Trial DetailsNCT04141891
Acute Coronary Syndrome, Aortic Stenosis, Subvalvular
La Jolla, California, United States
View Trial DetailsNCT03567239
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Lincoln, Nebraska, United States
View Trial DetailsNCT05561400
Aphasia, Aphasia, Broca
Duluth, Minnesota, United States
View Trial Details